vs
Ponce Financial Group, Inc.（PDLB）与RHYTHM PHARMACEUTICALS, INC.（RYTM）财务数据对比。点击上方公司名可切换其他公司
RHYTHM PHARMACEUTICALS, INC.的季度营收约是Ponce Financial Group, Inc.的1.8倍（$57.3M vs $31.4M），Ponce Financial Group, Inc.净利率更高（36.3% vs -83.0%，领先119.3%），Ponce Financial Group, Inc.同比增速更快（37.6% vs 36.9%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（48.5% vs 23.7%）
庞塞金融集团是总部位于美国的金融控股公司，核心子公司为庞塞银行，主要服务纽约大都会区的多元文化、移民及中低收入社区，提供存款账户、按揭贷款、小微企业融资、个人信贷等零售及商业银行服务。
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
PDLB vs RYTM — 直观对比
营收规模更大
RYTM
是对方的1.8倍
$31.4M
营收增速更快
PDLB
高出0.7%
36.9%
净利率更高
PDLB
高出119.3%
-83.0%
两年增速更快
RYTM
近两年复合增速
23.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $31.4M | $57.3M |
| 净利润 | $10.1M | $-47.5M |
| 毛利率 | — | 91.6% |
| 营业利润率 | 43.6% | -82.2% |
| 净利率 | 36.3% | -83.0% |
| 营收同比 | 37.6% | 36.9% |
| 净利润同比 | 245.6% | -9.6% |
| 每股收益（稀释后） | $0.43 | $-0.73 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PDLBRYTM
| Q4 25 | $31.4M | $57.3M | ||
| Q3 25 | $26.7M | $51.3M | ||
| Q2 25 | $26.5M | $48.5M | ||
| Q1 25 | $24.6M | $32.7M | ||
| Q4 24 | $22.8M | $41.8M | ||
| Q3 24 | $20.2M | $33.3M | ||
| Q2 24 | $20.2M | $29.1M | ||
| Q1 24 | $20.5M | $26.0M |
净利润PDLBRYTM
| Q4 25 | $10.1M | $-47.5M | ||
| Q3 25 | $6.5M | $-52.9M | ||
| Q2 25 | $6.1M | $-46.6M | ||
| Q1 25 | $6.0M | $-49.5M | ||
| Q4 24 | $2.9M | $-43.3M | ||
| Q3 24 | $2.4M | $-43.6M | ||
| Q2 24 | $3.2M | $-32.3M | ||
| Q1 24 | $2.4M | $-141.4M |
毛利率PDLBRYTM
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% | ||
| Q1 24 | — | 89.2% |
营业利润率PDLBRYTM
| Q4 25 | 43.6% | -82.2% | ||
| Q3 25 | 32.8% | -102.6% | ||
| Q2 25 | 30.2% | -93.4% | ||
| Q1 25 | 32.5% | -143.7% | ||
| Q4 24 | 19.6% | -98.6% | ||
| Q3 24 | 15.2% | -132.0% | ||
| Q2 24 | 21.8% | -139.2% | ||
| Q1 24 | 18.3% | -538.7% |
净利率PDLBRYTM
| Q4 25 | 36.3% | -83.0% | ||
| Q3 25 | 24.3% | -103.1% | ||
| Q2 25 | 23.0% | -96.1% | ||
| Q1 25 | 24.2% | -151.4% | ||
| Q4 24 | 14.1% | -103.6% | ||
| Q3 24 | 12.1% | -131.2% | ||
| Q2 24 | 15.8% | -110.9% | ||
| Q1 24 | 11.8% | -544.4% |
每股收益（稀释后）PDLBRYTM
| Q4 25 | $0.43 | $-0.73 | ||
| Q3 25 | $0.27 | $-0.82 | ||
| Q2 25 | $0.25 | $-0.75 | ||
| Q1 25 | $0.25 | $-0.81 | ||
| Q4 24 | $0.11 | $-0.71 | ||
| Q3 24 | $0.10 | $-0.73 | ||
| Q2 24 | $0.14 | $-0.55 | ||
| Q1 24 | $0.11 | $-2.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $126.2M | $388.9M |
| 总债务越低越好 | $596.1M | — |
| 股东权益账面价值 | $541.5M | $139.1M |
| 总资产 | $3.2B | $480.2M |
| 负债/权益比越低杠杆越低 | 1.10× | — |
8季度趋势，按日历期对齐
现金及短期投资PDLBRYTM
| Q4 25 | $126.2M | $388.9M | ||
| Q3 25 | $146.6M | $416.1M | ||
| Q2 25 | $126.6M | $291.0M | ||
| Q1 25 | $129.9M | $314.5M | ||
| Q4 24 | $139.8M | $320.6M | ||
| Q3 24 | $155.8M | $298.4M | ||
| Q2 24 | $103.2M | $319.1M | ||
| Q1 24 | $134.7M | $201.2M |
总债务PDLBRYTM
| Q4 25 | $596.1M | — | ||
| Q3 25 | $521.1M | — | ||
| Q2 25 | $536.1M | — | ||
| Q1 25 | $521.1M | — | ||
| Q4 24 | $596.1M | — | ||
| Q3 24 | $580.4M | — | ||
| Q2 24 | $680.4M | — | ||
| Q1 24 | $680.4M | — |
股东权益PDLBRYTM
| Q4 25 | $541.5M | $139.1M | ||
| Q3 25 | $529.8M | $148.8M | ||
| Q2 25 | $521.1M | $-11.9M | ||
| Q1 25 | $513.9M | $18.9M | ||
| Q4 24 | $505.5M | $21.7M | ||
| Q3 24 | $504.6M | $11.2M | ||
| Q2 24 | $497.7M | $39.3M | ||
| Q1 24 | $493.7M | $61.6M |
总资产PDLBRYTM
| Q4 25 | $3.2B | $480.2M | ||
| Q3 25 | $3.2B | $506.9M | ||
| Q2 25 | $3.2B | $372.7M | ||
| Q1 25 | $3.1B | $386.7M | ||
| Q4 24 | $3.0B | $392.3M | ||
| Q3 24 | $3.0B | $363.6M | ||
| Q2 24 | $2.8B | $381.8M | ||
| Q1 24 | $2.8B | $258.7M |
负债/权益比PDLBRYTM
| Q4 25 | 1.10× | — | ||
| Q3 25 | 0.98× | — | ||
| Q2 25 | 1.03× | — | ||
| Q1 25 | 1.01× | — | ||
| Q4 24 | 1.18× | — | ||
| Q3 24 | 1.15× | — | ||
| Q2 24 | 1.37× | — | ||
| Q1 24 | 1.38× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $55.6M | $-25.4M |
| 自由现金流经营现金流 - 资本支出 | $54.6M | — |
| 自由现金流率自由现金流/营收 | 173.9% | — |
| 资本支出强度资本支出/营收 | 3.1% | — |
| 现金转化率经营现金流/净利润 | 5.48× | — |
| 过去12个月自由现金流最近4个季度 | $74.3M | — |
8季度趋势，按日历期对齐
经营现金流PDLBRYTM
| Q4 25 | $55.6M | $-25.4M | ||
| Q3 25 | $1.4M | $-26.6M | ||
| Q2 25 | $6.2M | $-23.3M | ||
| Q1 25 | $13.1M | $-40.4M | ||
| Q4 24 | $7.2M | $-18.8M | ||
| Q3 24 | $-14.6M | $-25.2M | ||
| Q2 24 | $-2.6M | $-29.1M | ||
| Q1 24 | $1.5M | $-40.7M |
自由现金流PDLBRYTM
| Q4 25 | $54.6M | — | ||
| Q3 25 | $786.0K | — | ||
| Q2 25 | $5.9M | — | ||
| Q1 25 | $12.9M | — | ||
| Q4 24 | $4.5M | — | ||
| Q3 24 | $-15.0M | — | ||
| Q2 24 | $-2.6M | — | ||
| Q1 24 | $-315.0K | — |
自由现金流率PDLBRYTM
| Q4 25 | 173.9% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 22.4% | — | ||
| Q1 25 | 52.6% | — | ||
| Q4 24 | 19.7% | — | ||
| Q3 24 | -74.1% | — | ||
| Q2 24 | -13.0% | — | ||
| Q1 24 | -1.5% | — |
资本支出强度PDLBRYTM
| Q4 25 | 3.1% | — | ||
| Q3 25 | 2.3% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 11.9% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 8.7% | — |
现金转化率PDLBRYTM
| Q4 25 | 5.48× | — | ||
| Q3 25 | 0.21× | — | ||
| Q2 25 | 1.01× | — | ||
| Q1 25 | 2.20× | — | ||
| Q4 24 | 2.46× | — | ||
| Q3 24 | -5.99× | — | ||
| Q2 24 | -0.80× | — | ||
| Q1 24 | 0.61× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
